ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

Charlotte Carton; D. Gareth Evans; Ignacio Blanco; Reinhard E. Friedrich; Rosalie E. Ferner; Said Farschtschi; S.P. Hector; Amedeo A. Azizi; Victor Mautner; Claas Röhl; Sirkku Peltonen; Stavros Stivaros; Eric Legius; Rianne Oostenbrink; Joan Brunet; Frank Van Calenbergh; Cathérine Cassiman; Thomas Czech; María José Gavarrete de León; Henk Giele; Susie M.D. Henley; Conxi Lázaro; Vera Lipkovskaya; Eamonn R. Maher; Vanessa Martín; I.M.J. Mathijssen; Enrico Opocher; Ana Elisabete Pires; Thomas Pletschko; Eirene Poupaki; Vita Ridola; André B. Rietman; Thorsten Rosenbaum; Alastair Santhouse; Astrid Sehested; Ian Simmons; Walter Taal; Anja Wagner

doi:10.1016/j.eclinm.2022.101818

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

This guideline has been supported by the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS). ERN GENTURIS is funded by the European Union. DGE is supported by the Manchester NIHRBiomedical Research Centre (IS-BRC-1215-20007).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Carton et al. (2023) studied this question.

synapsesocial.com/papers/69dff5b31827a1d0b125575d https://doi.org/10.1016/j.eclinm.2022.101818

View Full Paper

Ask AI

Bookmark

Share

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

Ask about this paper

Abstract

Discussion

Cite This Study

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading